Tag:
New Zealand
Latest Headlines
Latest Headlines
NZ officials under fire over Pradaxa side effects
New Zealand drug regulators are in the hot seat after two patients using Boehringer Ingelheim's new blood thinner Pradaxa died and 36 others suffered severe bleeding. NZ's Pharmac added the new
New Zealand device companies, research work shine
FierceMedicalDevices recently caught up with several New Zealand-based medical device companies at AdvaMed 2010:The MedTech Conference. Several had many promising devices either already on the market
SPOTLIGHT: NZ Activists challenge Herceptin denial
Breast Cancer survivors in New Zealand won a small victory in their challenge to the government's decision not to fund a full course of Herceptin treatment; the women have won the right to see
ALSO NOTED: Gene Logic takes second look at Merck KGaA drugs; Zars mounts IPO;
> A subsidiary of Germany-based Merck KGaA has inked a deal to help reposition and develop several of Gene Logic's potential drugs. The candidates had been subject of previous clinical trials
ALSO NOTED: New Zealand bans high dose of Prexige; Merck, Newron continue safinamide development;
> Add New Zealand to the list of countries banning high doses of Prexige, Novartis' Cox-2 inhibitor that's been linked to liver damage. Both 200 mg and 400 mg strengths will be pulled from the
